Evommune Statistics

Total Valuation

Evommune has a market cap or net worth of $658.70 million. The enterprise value is $572.67 million.

Market Cap	658.70M
Enterprise Value	572.67M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Evommune has 30.08 million shares outstanding.

Current Share Class	30.08M
Shares Outstanding	30.08M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.30%
Owned by Insiders (%)	2.75%
Owned by Institutions (%)	5.63%
Float	14.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	93.96
Forward PS	n/a
PB Ratio	7.68
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	190.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.40, with a Debt / Equity ratio of 0.01.

Current Ratio	9.40
Quick Ratio	8.60
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,618.86

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-88.25%
Revenue Per Employee	$66,667
Profits Per Employee	-$1.47M
Employee Count	45
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	61.46
Average Volume (20 Days)	93,106

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Evommune had revenue of $3.00 million and -$66.26 million in losses. Loss per share was -$5.15.

Revenue	3.00M
Gross Profit	3.00M
Operating Income	-76.00M
Pretax Income	-64.76M
Net Income	-66.26M
EBITDA	-74.55M
EBIT	-76.00M
Loss Per Share	-$5.15

Full Income Statement

Balance Sheet

The company has $86.80 million in cash and $771,000 in debt, giving a net cash position of $86.02 million or $2.86 per share.

Cash & Cash Equivalents	86.80M
Total Debt	771,000
Net Cash	86.02M
Net Cash Per Share	$2.86
Equity (Book Value)	85.77M
Book Value Per Share	-12.93
Working Capital	84.80M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-94.85M
Capital Expenditures	n/a
Free Cash Flow	-94.85M
FCF Per Share	-$3.15

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,533.20%
Pretax Margin	-2,158.80%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Evommune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-10.06%
FCF Yield	-14.40%

Analyst Forecast

The average price target for Evommune is $39.33, which is 79.59% higher than the current price. The consensus rating is "Buy".

Price Target	$39.33
Price Target Difference	79.59%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Evommune has an Altman Z-Score of -4.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.14
Piotroski F-Score	n/a